Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report Parthika Patel6 April 2026 9:20 PM ISTNew Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin,...
Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX Susmita Roy3 April 2026 3:23 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark infringement, the Delhi High Court in the case of Sun Pharma Laboratories Limited vs...
NSQ Drug Alert: 60 Batches Including Paracetamol, Cefixime, Telmisartan Fail CDSCO Quality Tests in February Susmita Roy24 March 2026 11:18 AM ISTNew Delhi: In a fresh drug alert highlighting ongoing quality surveillance, 60 batches of drugs and medical devices have been declared Not of Standard...
SC Seeks Centre, DCGI Response on Micro Labs' Plea Against Anti-Diabetic FDC Ban Susmita Roy26 Feb 2026 10:26 PM ISTNew Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro...
From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route Susmita Roy26 Jan 2026 1:58 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and December 2025 for...
CDSCO Committee Seeks Efficacy-Focused Redesign of Intas' Pembrolizumab Clinical Trial Susmita Roy9 Dec 2025 6:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has advised Intas Pharmaceuticals to...
Intas Pharma appoints Vijay Dabade as Associate Vice President - Quality Control Ruchika Sharma28 Nov 2025 1:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Vijay Dabade as Associate Vice President - Quality Control at the company.With...
Intas Pharma Gets CDSCO Panel Nod to Conduct Phase I Trial of Pertuzumab, Trastuzumab Solution for Injection Susmita Roy26 Nov 2025 6:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Intas...
Intas Pharma appoints Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing Laboratory Ruchika Sharma17 Nov 2025 4:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing Laboratory at the...
Intas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing Finance Ruchika Sharma10 Nov 2025 2:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Sujit Mandal as Associate Vice President – Manufacturing Finance.Sujit brings rich...
Intas Pharma appoints Gagan Bharadwaj as Executive Vice President - Supply Chain Management Ruchika Sharma15 Oct 2025 2:45 PM ISTAhmedabad: Intas Pharma has announced the appointment of Gagan Bharadwaj as Executive Vice President - Supply Chain Management."Throughout...
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Farhat Nasim30 Sept 2025 3:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...
